Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure, Semin Oncol, vol.19, pp.47-84, 1992. ,
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT, British Journal of Haematology, vol.84, issue.1, pp.1020-1026, 1999. ,
DOI : 10.1038/sj.leu.2400795
Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia, Blood, vol.76, pp.1083-91, 1990. ,
13-cis retinoic acid treatment for myelodysplastic syndromes., Journal of Clinical Oncology, vol.4, issue.4, pp.589-95, 1986. ,
DOI : 10.1200/JCO.1986.4.4.589
Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes, Hematol Oncol Clin North Am, vol.7, pp.477-93, 1993. ,
Treatment of therapy-related leukemia and myelodysplastic syndrome, Hematol Oncol Clin North Am, vol.7, pp.81-107, 1993. ,
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series, Blood, vol.102, issue.1, pp.43-52, 2003. ,
DOI : 10.1182/blood-2002-11-3343
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone , cyclophosphamide, fluorouracil and radiation therapy, Annals of Oncology, vol.11, issue.10, pp.1289-94, 2000. ,
DOI : 10.1023/A:1008375016038
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies, Journal of Cancer Research and Clinical Oncology, vol.124, issue.3-4, pp.207-221, 1998. ,
DOI : 10.1007/s004320050156
Secondary leukemias induced by topoisomerase-targeted drugs, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1400, issue.1-3, pp.233-55, 1998. ,
DOI : 10.1016/S0167-4781(98)00139-0
Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors., Journal of Clinical Oncology, vol.16, issue.5, pp.1897-1905, 1998. ,
DOI : 10.1200/JCO.1998.16.5.1897
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature., Journal of Clinical Oncology, vol.11, issue.12, pp.2370-2379, 1993. ,
DOI : 10.1200/JCO.1993.11.12.2370
Myelodysplastic Syndromes Sub- committee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) ,
Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients???Report of the French Society of Bone Marrow Transplantation, Journal of Clinical Oncology, vol.18, issue.5, pp.963-71, 2000. ,
DOI : 10.1200/JCO.2000.18.5.963
URL : https://hal.archives-ouvertes.fr/hal-00127357
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders, Blood, vol.110, issue.4, pp.1379-87, 2007. ,
DOI : 10.1182/blood-2007-02-076307
Therapy-Related Myelodysplastic Syndrome, American Journal of Clinical Pathology, vol.127, issue.2, pp.197-205, 2007. ,
DOI : 10.1309/NQ3PMV4U8YV39JWJ
Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation, Biology of Blood and Marrow Transplantation, vol.13, issue.6, pp.655-64, 2007. ,
DOI : 10.1016/j.bbmt.2007.01.079
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT), British Journal of Haematology, vol.67, issue.3, pp.620-650, 2000. ,
DOI : 10.1038/sj.bmt.1701084
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia, Bone Marrow Transplantation, vol.20, issue.9, pp.737-780, 1997. ,
DOI : 10.1038/sj.bmt.1700971
Secondary acute myeloid leukemia has a worse outcome in MRC trials, Blood, vol.100, p.88, 2002. ,
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, vol.18, issue.1, pp.120-125, 2004. ,
DOI : 10.1038/sj.leu.2403187
Prognosis in Therapy-Related Acute Myeloid Leukemia and Impact of Karyotype, Journal of Clinical Oncology, vol.22, issue.12, pp.2510-2511, 2004. ,
DOI : 10.1200/JCO.2004.99.301
Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey, Bone Marrow Transplantation, vol.21, issue.12, pp.1213-1219, 1998. ,
DOI : 10.1038/sj.bmt.1701269
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program, Blood, vol.99, issue.6, pp.1943-51, 2002. ,
DOI : 10.1182/blood.V99.6.1943
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes, Blood, vol.108, issue.3, pp.836-882, 2006. ,
DOI : 10.1182/blood-2005-11-4503